Luxembourg Agency for Research Integrity, Esch-sur-Alzette, Luxembourg
Bond University Faculty of Health Sciences and Medicine, Gold Coast, Queensland, Australia.
J Med Ethics. 2020 Dec;46(12):803-807. doi: 10.1136/medethics-2020-106494. Epub 2020 Oct 1.
Worldwide there are currently over 1200 research studies being performed on the topic of COVID-19. Many of these involve children and adults over age 65 years. There are also numerous studies testing investigational vaccines on healthy volunteers. No research team is exempt from the pressures and speed at which COVID-19 research is occurring. And this can increase the risk of honest error as well as misconduct. To date, 33 papers have been identified as unsuitable for public use and either retracted, withdrawn, or noted with concern. Asia is the source of most of these manuscripts (n=19; 57.6%) with China the largest Asian subgroup (n=11; 57.9%). This paper explores these findings and offers guidance for responsible research practice during pandemics.
目前，全球有超过 1200 项研究正在进行 COVID-19 相关研究。其中许多研究涉及儿童和 65 岁以上的成年人。还有许多研究正在对健康志愿者进行试验性疫苗测试。没有任何研究团队能够免受 COVID-19 研究的压力和速度的影响。这可能会增加诚实错误和不当行为的风险。迄今为止，已经确定有 33 篇论文不适合公开使用，要么被撤回，要么被撤回，要么被撤回。亚洲是这些论文的主要来源（n=19；57.6%），中国是最大的亚洲亚组（n=11；57.9%）。本文探讨了这些发现，并为大流行期间的负责任研究实践提供了指导。
